Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXI8BS
|
||||
Drug Name |
(R)-1-((1H-imidazol-5-yl)methyl)-3-benzyl-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonitrile
|
||||
Synonyms |
BMS-214662; CHEMBL351706
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H23N5O2S2
|
||||
Canonical SMILES |
O=S(=O)(N1Cc2cc(ccc2N(Cc3c[nH]cn3)C[C@H]1Cc4ccccc4)C#N)c5cccs5
|
||||
InChI |
InChI=1S/C25H23N5O2S2/c26-13-20-8-9-24-21(11-20)15-30(34(31,32)25-7-4-10-33-25)23(12-19-5-2-1-3-6-19)17-29(24)16-22-14-27-18-28-22/h1-11,14,18,23H,12,15-17H2,(H,27,28)/t23-/m1/s1
|
||||
InChIKey |
OLCWFLWEHWLBTO-HSZRJFAPSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.